SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-055632
Filing Date
2020-11-30
Accepted
2020-11-30 16:54:53
Documents
2
Period of Report
2020-11-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-8k_20201130.htm 8-K 35570
2 EX-3.1 apvo-ex31_6.htm EX-3.1 198397
  Complete submission text file 0001564590-20-055632.txt   235162
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 201358697
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences